Trial intelligence / Profile preview

Asoprisnil in Uterine Leiomyomata

NCT00152256Phase 3Completed

Sponsor
Abbott Laboratories
Start
Sep 2003
Primary completion
Feb 2005
01

Overview

A Phase 3 trial of asoprisnil in uterine leiomyoma, sponsored by Abbott Laboratories. Started Sep 2003; status: completed.

02

Drugs

asoprisnil
03

Conditions

uterine leiomyoma

Beyond the preview

Go deeper on NCT00152256.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00152256.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call